Gilead Sciences, Inc.
About Gilead Sciences, Inc.
Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.
2107 articles with Gilead Sciences, Inc.
-
Gilead Sciences, Inc. Files Second Patent Infringement Lawsuit Against TEVA Pharmaceuticals USA
5/15/2009
-
Gilead Sciences, Inc. Profit Rises a Higher-than-Expected 21 Percent
4/22/2009
-
Gilead Sciences, Inc. Initiates Phase II Clinical Trial of Integrase-Based, Single-Tablet, Once-Daily Regimen for the Treatment of HIV
4/17/2009
-
Gilead Sciences, Inc. to Release First Quarter 2009 Financial Results on Tuesday, April 21, 2009
4/15/2009
-
Gilead Sciences, Inc. Successfully Completes Tender Offer for Shares of CV Therapeutics, Inc. With Over 88 Percent of Shares Tendered
4/15/2009
-
Phase III Data for Gilead Sciences, Inc.'s Darusentan Accepted as Late-Breaker Presentation at American Society of Hematology 2009
4/13/2009
-
Gilead Sciences, Inc. Announces Notification of ANDA Filing for Atripla(R)
4/7/2009
-
Gilead Sciences, Inc. Phase III Clinical Trial of Darusentan for Resistant Hypertension Meets Primary Endpoints
4/3/2009
-
Gilead Sciences, Inc. Announces Early Termination of Hart-Scott-Rodino Waiting Period
4/1/2009
-
Gilead Sciences, Inc. Initiates Phase II Clinical Trial of Cicletanine for the Treatment of Pulmonary Arterial Hypertension
3/25/2009
-
European CHMP Adopts Negative Opinion on Gilead Sciences, Inc.'s Aztreonam Lysine
3/19/2009
-
Department of Justice Declines to Intervene in False Claims Act Lawsuits Against Gilead Sciences, Inc.
3/16/2009
-
CV Therapeutics, Inc.'s (JOBS) Board of Directors Rejects Astellas Pharma Inc.'s (JOBS) Tender Offer
3/13/2009
-
Gilead Sciences, Inc. to Present at the Cowen and Company 29th Annual Healthcare Conference on Monday, March 16
3/12/2009
-
Gilead Sciences, Inc. Buying CV Therapeutics, Inc. for $1.4 Billion
3/12/2009
-
Gilead Sciences, Inc. to Present at the Cowen and Company 29th Annual Healthcare Conference on Monday, March 16
3/11/2009
-
Gilead Sciences, Inc. to Present at the Barclays Capital Global Healthcare Conference on Tuesday, March 10
3/9/2009
-
Gilead Sciences, Inc. Receives Response From U.S. FDA on Company's Request for Formal Dispute Resolution for Aztreonam for Inhalation Solution
2/19/2009
-
Gilead Sciences, Inc. to Present at the 11th Annual Biotechnology Industry Organization (BIO) CEO Investor Conference on Tuesday, February 10
2/9/2009
-
Gilead Sciences, Inc. Completes Acquisition of Building and Associated Land from EFI
1/30/2009